Kolon Life Science H1 2025 Earnings Analysis: Turnaround or Trap?
Kolon Life Science: Is a Turnaround Finally Here? Kolon Life Science has finally returned to profitability in the first half of 2025. The robust growth of its chemical division and the potential of its bio segment are attracting investor attention. However, there’s more to the story than just the positives. A thorough analysis of the … Read more